Literature DB >> 15192438

Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation.

Alexandre Fredenrich1, Paul A Grimaldi.   

Abstract

PURPOSE OF THE REVIEW: Peroxisome proliferator-activated receptors mediate the transcriptional effects of fatty acids and fatty acid metabolites and regulate many physiological functions including development and metabolism. The roles of peroxisome proliferator-activated receptor alpha and gamma isotypes have been well established, while the functions of the third member of the family, peroxisome proliferator-activated receptor delta, remained unclear until very recently. This review focuses on the physiological functions of the nuclear receptor and especially on its roles in the control of fatty acid metabolism. RECENT
FINDINGS: We review very recent data demonstrating that peroxisome proliferator-activated receptor delta plays a central role in the regulation of fatty acid oxidation in several tissues, such as skeletal muscle and adipose tissue, and also that the nuclear receptor is involved in cholesterol metabolism.
SUMMARY: Use of potent and specific peroxisome proliferator-activated receptor delta agonists and appropriate transgenic animal models revealed the importance of this nuclear receptor in regulation of fatty acid catabolism in skeletal muscle and other tissues. It also indicated the potential of peroxisome proliferator-activated receptor delta as a therapeutic target in pathologies such as metabolic syndrome. However, the effects of peroxisome proliferator-activated receptor delta activation in atherosclerosis and the control of cell proliferation remain to be established.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192438     DOI: 10.1097/01.mco.0000134370.93686.0a

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  6 in total

1.  Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.

Authors:  Raquel Villegas; Scott Williams; Yutang Gao; Qiuyin Cai; Honglan Li; Tom Elasy; Hui Cai; Todd Edwards; Yong-Bing Xiang; Wei Zheng; Jirong Long; Xiao Ou Shu
Journal:  Ann Hum Genet       Date:  2011-09       Impact factor: 1.670

2.  Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm.

Authors:  Kenneth R Feingold; Arthur Moser; Sophie M Patzek; Judy K Shigenaga; Carl Grunfeld
Journal:  J Lipid Res       Date:  2009-05-14       Impact factor: 5.922

Review 3.  Potential mechanisms of muscle mitochondrial dysfunction in aging and obesity and cellular consequences.

Authors:  Emilie Chanséaume; Béatrice Morio
Journal:  Int J Mol Sci       Date:  2009-01-13       Impact factor: 6.208

4.  Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population.

Authors:  Minjoo Kim; Minkyung Kim; Hye Jin Yoo; Jayoung Shon; Jong Ho Lee
Journal:  Hum Genomics       Date:  2018-06-18       Impact factor: 4.639

Review 5.  Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis.

Authors:  Jeffrey M Peters; Vonn Walter; Andrew D Patterson; Frank J Gonzalez
Journal:  NPJ Precis Oncol       Date:  2019-10-07

6.  NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?

Authors:  Gerardo G Mackenzie; Shaheen Rasheed; William Wertheim; Basil Rigas
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.